Approved new medicines should be available to public patients within 180 days of a HSE cost assessment decision, a conference on access to new drugs has heard today.
The new access system is to be phased in over the next three years as part of an agreement between the State and the pharmaceutical industry.
Pamela Deasy(Patient Advocate) “Upon hearing that access to new medicines could drop from around 600 days to 180 for public patients sounds promising ………. When you’re facing an aggressive illness, months matter, and what fundamentally will actually change in the system to make sure these timelines are real, consistent, and centred around patient urgency rather than targets on paper?
Because for many of us, faster access isn’t just a policy goal, it’s time we simply don’t have 😔 especially relation to poor prognosis cancers.“
https://www.rte.ie/news/2026/0430/1571070-public-access-drugs/
Lynch Syndrome Ireland 